Blistex Lip Medex Recalled Due to Improper Storage Conditions
Family Dollar Stores is recalling specific Blistex Lip Medex products (SKUs 906120 and 998852) distributed April to June 2022 due to storage outside proper temperature conditions during distribution.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses, injuries, or hospitalizations. The hazard is a storage temperature deviation affecting manufacturing compliance and product stability, not an acute safety threat. It aligns with precautionary recalls involving quality/compliance issues rather than direct harm.
Plain-English summary
Family Dollar Stores, Llc. is recalling specific Blistex Lip Medex topical products due to Current Good Manufacturing Practice (CGMP) deviations.
The recalled products are Blistex Lip Medex 0.25 oz (SKU 906120) and Blistex Lip Medex Pot 0.38 oz (SKU 998852), distributed to specific Family Dollar Store locations from April 30, 2022 through June 10, 2022.
The products were held outside appropriate storage temperature conditions during distribution. This represents a deviation from required manufacturing and storage practices and may affect product stability and efficacy.
Consumers who have these products should stop using them. For questions about the recall, contact Family Dollar Stores, Llc.
The recalled product
- Product
- BLISTEX LIP MEDEX 0.25OZ SKU 906120 BLISTEX LIP MEDEX POT 0.38 OZ SKU 998852 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — OTC Topical
- Hazard
- improper-storage-temperature
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 906120
- 998852
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27